COMMON STOCKS – 98.5%

Financials – 28.6%

Banks – 16.4%

AIB Group PLC

Bank Leumi Le-Israel BM

BAWAG Group AG^(a)

KBC Group NV

Mitsubishi UFJ Financial Group, Inc.

NatWest Group PLC

Nordea Bank Abp

Oversea-Chinese Banking Corp., Ltd.

Royal Bank of Canada

Sumitomo Mitsui Financial Group, Inc.

Toronto-Dominion Bank (The)

UniCredit SpA

Capital Markets – 4.3%

Euronext NV^(a)

IG Group Holdings PLC

London Stock Exchange Group PLC

Singapore Exchange Ltd.

Insurance – 7.9%

AIA Group Ltd. - Class H

AXA SA

Beazley PLC

Medibank Pvt. Ltd.

NN Group NV

Phoenix Financial Ltd.

Tryg A/S

Industrials – 19.0%

Aerospace & Defense – 4.0%

BAE Systems PLC

Safran SA

Construction & Engineering – 2.3%

Stantec, Inc.

Vinci SA

Electrical Equipment – 5.3%

ABB Ltd. (REG)

Prysmian SpA

Schneider Electric SE

Industrial Conglomerates – 0.6%

Hitachi Ltd.

Machinery – 1.2%

Weir Group PLC (The)

Passenger Airlines – 1.0%

Ryanair Holdings PLC

Professional Services – 2.7%

Persol Holdings Co., Ltd.

RELX PLC

Wolters Kluwer NV

Trading Companies & Distributors – 1.9%

BOC Aviation Ltd. - Class H^(a)

Bunzl PLC

Consumer Discretionary – 11.4%

Automobiles – 0.6%

Honda Motor Co., Ltd.^(b)

Broadline Retail – 1.0%

Canadian Tire Corp., Ltd. - Class A^(b)

Diversified Consumer Services – 1.1%

Pearson PLC

Hotels, Restaurants & Leisure – 3.9%

Amadeus IT Group SA

Aristocrat Leisure Ltd.

Compass Group PLC

Lottomatica Group SpA

Household Durables – 3.2%

Open House Group Co., Ltd.

Sony Group Corp.

Specialty Retail – 1.6%

Industria de Diseno Textil SA

Consumer Staples – 9.8%

Consumer Staples Distribution & Retail – 2.6%

Koninklijke Ahold Delhaize NV

Tesco PLC

Food Products – 4.1%

Danone SA

Glanbia PLC

Kerry Group PLC - Class A

Salmar ASA

Toyo Suisan Kaisha Ltd.

Household Products – 0.9%

Reckitt Benckiser Group PLC

Tobacco – 2.2%

British American Tobacco PLC

Philip Morris International, Inc.

Health Care – 9.4%

Health Care Providers & Services – 1.0%

Fresenius SE & Co. KGaA

Galenica AG^{(a) (c)}

Pharmaceuticals – 8.4%

AstraZeneca PLC

Chugai Pharmaceutical Co., Ltd.

Haleon PLC

Novartis AG (REG)

Novo Nordisk A/S - Class B

Roche Holding AG

Takeda Pharmaceutical Co., Ltd.

Information Technology – 8.0%

IT Services – 1.8%

BIPROGY, Inc.

Nomura Research Institute Ltd.

Obic Co., Ltd.^(b)

Semiconductors & Semiconductor Equipment – 4.1%

ASML Holding NV

Taiwan Semiconductor Manufacturing Co., Ltd.

Software – 2.1%

Nice Ltd.^(c)

SAP SE

Communication Services – 3.5%

Diversified Telecommunication Services – 1.9%

HKT Trust & HKT Ltd. - Class H

Koninklijke KPN NV

Interactive Media & Services – 0.4%

Autotrader Group PLC

Media – 1.2%

Informa PLC

Utilities – 3.4%

Electric Utilities – 1.7%

Enel SpA

Multi-Utilities – 1.7%

National Grid PLC

Energy – 2.9%

Oil, Gas & Consumable Fuels – 2.9%

ENEOS Holdings, Inc.

Shell PLC

TotalEnergies SE

Real Estate – 1.7%

Real Estate Management & Development – 1.7%

Mitsui Fudosan Co., Ltd.

Materials – 0.8%

Metals & Mining – 0.8%

Rio Tinto Ltd.^(b)

Total Common Stocks
(cost $1,306,113,121)

WARRANTS – 0.0%

Information Technology – 0.0%

Software – 0.0%

Constellation Software, Inc./Canada, expiring 03/31/2040^{(c) (d) (e)}
(cost $0)

SHORT-TERM INVESTMENTS – 0.9%

Investment Companies – 0.9%

AB Fixed Income Shares, Inc. - Government Money Market Portfolio - Class AB, 3.53%^{(f) (g) (h)}
(cost $16,556,871)

Total Investments Before Security Lending Collateral for Securities Loaned – 99.4%
(cost $1,322,669,992)

INVESTMENTS OF CASH COLLATERAL FOR SECURITIES LOANED – 0.6%

Investment Companies – 0.6%

AB Fixed Income Shares, Inc. - Government Money Market Portfolio - Class AB, 3.53%^{(f) (g) (h)}
(cost $10,751,360)

Total Investments – 100.0%
(cost $1,333,421,352)⁽ⁱ⁾

Other assets less liabilities – 0.0%

Net Assets – 100.0%

Contracts to

Deliver

(000)

In Exchange

For

(000)

Settlement

Date

Unrealized

Appreciation

(Depreciation)

Security is exempt from registration under Rule 144A or Regulation S of the Securities Act of 1933. These securities are considered restricted, but liquid and may be resold in transactions exempt from registration. At February 28, 2026, the aggregate market value of these securities amounted to $85,688,696 or 4.9% of net assets.

Represents entire or partial securities out on loan.

Non-income producing security.

Security in which significant unobservable inputs (Level 3) were used in determining fair value.

Fair valued by the Adviser.

The rate shown represents the 7-day yield as of period end.

Affiliated investments.

To obtain a copy of the fund’s shareholder report, please go to the Securities and Exchange Commission’s website at www.sec.gov. Additionally, shareholder reports for AB funds can be obtained by calling AB at (800) 227-4618.

As of February 28, 2026, the cost basis of investment securities owned was substantially identical for both book and tax purposes. Gross unrealized appreciation of investments was $432,042,682 and gross unrealized depreciation of investments was $(19,706,931), resulting in net unrealized appreciation of $412,335,751.

Please note: The sector classifications presented herein are based on the Global Industry Classification Standard (GICS) which was developed by Morgan Stanley Capital International and Standard & Poor’s. The components are divided into sector, industry group, and industry sub-indices as classified by the GICS for each of the market capitalization indices in the broad market.

The Fund’s country breakdown is expressed as a percentage of total investments (excluding security lending collateral) and may vary over time. The Fund also enters into derivative transactions, which may be used for hedging or investment purposes (see “Portfolio of Investments” section of the report for additional details). “Other” country weightings represent 2.2% or less in the following: Austria, Belgium, China, Denmark, Finland, Germany, Hong Kong, Israel and Norway.

Level 1 - quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

Level 3 - significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

Investments in Securities:

See Portfolio of Investments for sector classifications.

The Fund held securities with zero market value at period end.

Other financial instruments include derivative instruments, such as futures, forwards and swaps. Derivative instruments are valued at the unrealized appreciation (depreciation) on the instrument. Other financial instruments may also include swaps with upfront premiums, written options and written swaptions which are valued at market value.

Purchases

at Cost

(000)

Dividend

Income
(000)

Investments of cash collateral for securities lending transactions.